MEP55308A - New pharmaceutical compositions containing flibanserin polymorph a - Google Patents

New pharmaceutical compositions containing flibanserin polymorph a

Info

Publication number: MEP55308A
Authority: ME; Montenegro
Prior art keywords: pharmaceutical compositions; compositions containing; new pharmaceutical; flibanserin polymorph; containing flibanserin
Prior art date: 2002-05-22

Application number

MEP-553/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Thomas Friedl

Guido Bernhard Edmund Radtke

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-22

Filing date

2003-05-19

Publication date

2011-05-10

2003-05-19 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2011-05-10 Publication of MEP55308A publication Critical patent/MEP55308A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

MEP-553/08A 2002-05-22 2003-05-19 New pharmaceutical compositions containing flibanserin polymorph a MEP55308A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02011224		2002-05-22
PCT/EP2003/005226 WO2003097058A1 (en)	2002-05-22	2003-05-19	New pharmaceutical compositions containing flibanserin polymorph a
YU98704A RS51718B (sr)	2002-05-22	2003-05-19	Nove farmaceutske kompozicije koje sadrže flibanserin polimorf a

Publications (1)

Publication Number	Publication Date
MEP55308A true MEP55308A (en)	2011-05-10

Family

ID=29433081

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-553/08A MEP55308A (en)	2002-05-22	2003-05-19	New pharmaceutical compositions containing flibanserin polymorph a

Country Status (25)

Country	Link
EP (1)	EP1511489B1 (es)
JP (1)	JP3919788B2 (es)
KR (1)	KR101054237B1 (es)
CN (3)	CN101002780A (es)
AT (1)	ATE499939T1 (es)
BR (1)	BRPI0311189B8 (es)
CA (1)	CA2483597C (es)
CY (1)	CY1111470T1 (es)
DE (1)	DE60336225D1 (es)
DK (1)	DK1511489T3 (es)
EA (1)	EA007185B1 (es)
EC (1)	ECSP045493A (es)
ES (1)	ES2361994T3 (es)
HR (1)	HRP20041092B1 (es)
IL (1)	IL164440A0 (es)
ME (1)	MEP55308A (es)
MX (1)	MXPA04011487A (es)
NO (1)	NO329414B1 (es)
NZ (1)	NZ537253A (es)
PL (1)	PL211062B1 (es)
RS (1)	RS51718B (es)
SI (1)	SI1511489T1 (es)
UA (1)	UA80135C2 (es)
WO (1)	WO2003097058A1 (es)
ZA (1)	ZA200408151B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7183410B2 (en)	2001-08-02	2007-02-27	Bidachem S.P.A.	Stable polymorph of flibanserin
US10675280B2 (en)	2001-10-20	2020-06-09	Sprout Pharmaceuticals, Inc.	Treating sexual desire disorders with flibanserin
UA78974C2 (en)	2001-10-20	2007-05-10	Boehringer Ingelheim Pharma	Use of flibanserin for treating disorders of sexual desire
US20050239798A1 (en) *	2004-04-22	2005-10-27	Boehringer Ingelheim Pharmaceuticals, Inc.	Method for the treatment of premenstrual and other female sexual disorders
WO2006096439A2 (en) *	2005-03-04	2006-09-14	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
CA2608363A1 (en) *	2005-05-19	2006-11-23	Boehringer Ingelheim International Gmbh	Method for the treatment of drug-induced sexual dysfunction
WO2006125041A1 (en) *	2005-05-19	2006-11-23	Boehringer Ingelheim International Gmbh	Method for the treatment of sexual dysfunctions due to medical conditions
PL1912650T3 (pl)	2005-08-03	2018-01-31	Sprout Pharmaceuticals Inc	Zastosowanie flibanseryny w leczeniu otyłości
CA2626134C (en)	2005-10-29	2013-12-24	Boehringer Ingelheim International Gmbh	Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) *	2005-11-08	2007-05-10	Stephane Pollentier	Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
EP2037927B1 (en) *	2006-06-30	2010-01-27	Boehringer Ingelheim International GmbH	Flibanserin for the treatment of urinary incontinence and related diseases
AR062320A1 (es)	2006-08-14	2008-10-29	Boehringer Ingelheim Int	Formulaciones de flibanserina y metodo para fabricarlas
CL2007002214A1 (es)	2006-08-14	2008-03-07	Boehringer Ingelheim Int	Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
WO2008022932A2 (en)	2006-08-25	2008-02-28	Boehringer Ingelheim International Gmbh	Controlled release system and method for manufacturing the same
US8722682B2 (en)	2006-12-20	2014-05-13	Sprout Pharmaceuticals, Inc.	Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
EP1955699A1 (en) *	2007-02-08	2008-08-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Use of flibanserin for the treatment of insomnia
CL2008002693A1 (es)	2007-09-12	2009-10-16	Boehringer Ingelheim Int	Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
EP2090297A1 (en) *	2008-02-13	2009-08-19	Boehringer Ingelheim International GmbH	Formulations of flibanserin
DE102008047910A1 (de)	2008-09-19	2010-03-25	Molkerei Meggle Wasserburg Gmbh & Co. Kg	Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US20120010216A1 (en) *	2010-07-06	2012-01-12	Brown Arthur M	Pharmaceutical compositions containing vanoxerine
CN104926734B (zh) *	2015-07-07	2017-04-05	苏州立新制药有限公司	氟班色林的制备方法
WO2017128932A1 (zh) *	2016-01-31	2017-08-03	孟晓明	氟班色林的新晶型及其制备方法及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1251144B (it) *	1991-07-30	1995-05-04	Boehringer Ingelheim Italia	Derivati del benzimidazolone
RS50742B (sr) *	2001-08-02	2010-08-31	Bidachem S.P.A.	Stabilni polimorf flibanserina, postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
DE10138273A1 (de) *	2001-08-10	2003-02-27	Boehringer Ingelheim Pharma	Arzneimittel mit neuroprotektiver Wirkung

2003
- 2003-05-19 HR HRP20041092AA patent/HRP20041092B1/hr not_active IP Right Cessation
- 2003-05-19 RS YU98704A patent/RS51718B/sr unknown
- 2003-05-19 DE DE60336225T patent/DE60336225D1/de not_active Expired - Lifetime
- 2003-05-19 MX MXPA04011487A patent/MXPA04011487A/es active IP Right Grant
- 2003-05-19 SI SI200331994T patent/SI1511489T1/sl unknown
- 2003-05-19 AT AT03730069T patent/ATE499939T1/de active
- 2003-05-19 CN CNA2007100014771A patent/CN101002780A/zh active Pending
- 2003-05-19 CN CN201110122058XA patent/CN102240289A/zh active Pending
- 2003-05-19 ES ES03730069T patent/ES2361994T3/es not_active Expired - Lifetime
- 2003-05-19 BR BRPI0311189A patent/BRPI0311189B8/pt not_active IP Right Cessation
- 2003-05-19 ME MEP-553/08A patent/MEP55308A/xx unknown
- 2003-05-19 UA UA20041210555A patent/UA80135C2/uk unknown
- 2003-05-19 DK DK03730069.6T patent/DK1511489T3/da active
- 2003-05-19 EA EA200401515A patent/EA007185B1/ru not_active IP Right Cessation
- 2003-05-19 EP EP03730069A patent/EP1511489B1/en not_active Expired - Lifetime
- 2003-05-19 CN CNA038117029A patent/CN1655789A/zh active Pending
- 2003-05-19 PL PL372457A patent/PL211062B1/pl unknown
- 2003-05-19 NZ NZ537253A patent/NZ537253A/en not_active IP Right Cessation
- 2003-05-19 CA CA2483597A patent/CA2483597C/en not_active Expired - Fee Related
- 2003-05-19 JP JP2004505057A patent/JP3919788B2/ja not_active Expired - Fee Related
- 2003-05-19 WO PCT/EP2003/005226 patent/WO2003097058A1/en not_active Ceased
- 2003-05-19 KR KR1020047018741A patent/KR101054237B1/ko not_active Expired - Lifetime
2004
- 2004-10-05 IL IL16444004A patent/IL164440A0/xx unknown
- 2004-10-08 ZA ZA200408151A patent/ZA200408151B/en unknown
- 2004-10-22 NO NO20044547A patent/NO329414B1/no not_active IP Right Cessation
- 2004-12-13 EC EC2004005493A patent/ECSP045493A/es unknown
2011
- 2011-05-17 CY CY20111100475T patent/CY1111470T1/el unknown

Also Published As

Publication number	Publication date
SI1511489T1 (sl)	2011-06-30
EP1511489A1 (en)	2005-03-09
AU2003240672A1 (en)	2003-12-02
CA2483597A1 (en)	2003-11-27
NZ537253A (en)	2007-09-28
CA2483597C (en)	2010-02-09
PL372457A1 (en)	2005-07-25
CN102240289A (zh)	2011-11-16
RS51718B (sr)	2011-10-31
PL211062B1 (pl)	2012-04-30
RS98704A (sr)	2006-12-15
JP2005530787A (ja)	2005-10-13
JP3919788B2 (ja)	2007-05-30
DK1511489T3 (da)	2011-05-02
EA007185B1 (ru)	2006-08-25
BR0311189A (pt)	2005-02-22
CN101002780A (zh)	2007-07-25
MXPA04011487A (es)	2005-02-14
DE60336225D1 (de)	2011-04-14
EP1511489B1 (en)	2011-03-02
ZA200408151B (en)	2006-06-28
NO329414B1 (no)	2010-10-18
CY1111470T1 (el)	2015-08-05
KR20040111668A (ko)	2004-12-31
ATE499939T1 (de)	2011-03-15
HRP20041092B1 (hr)	2013-05-31
HRP20041092A2 (en)	2005-06-30
UA80135C2 (en)	2007-08-27
IL164440A0 (en)	2005-12-18
ECSP045493A (es)	2005-03-10
CN1655789A (zh)	2005-08-17
NO20044547L (no)	2004-12-17
BRPI0311189B8 (pt)	2021-05-25
WO2003097058A1 (en)	2003-11-27
ES2361994T3 (es)	2011-06-27
BRPI0311189B1 (pt)	2019-04-09
EA200401515A1 (ru)	2005-06-30
KR101054237B1 (ko)	2011-08-08

Publication	Publication Date	Title
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UA96449C2 (en)	2011-11-10	Stable laquinimod preparations
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
ZA200606173B (en)	2008-01-08	Effervescent oral opiate dosage form
TW200505875A (en)	2005-02-16	Novel compounds
AP1787A (en)	2007-10-04	Novel perindopril salt and pharmaceutical compositions containing same.
IL162765A (en)	2012-04-30	Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
PL364598A1 (en)	2004-12-13	Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2004093800A3 (en)	2005-01-06	Thyronamine derivatives and analogs and methods of use thereof
PL394600A1 (pl)	2011-07-18	Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
TW200509992A (en)	2005-03-16	Dosage form containing pantoprazole as active ingredient
AU2003231920A8 (en)	2003-10-13	Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
TW200503785A (en)	2005-02-01	Dosage form containing (S)-pantoprazole as active ingredient
MY142076A (en)	2010-08-30	Emulsifying systems containing azetidine derivatives
NO20064808L (no)	2006-12-15	Orale matrixformuleringer med licarbazepin
TW200503783A (en)	2005-02-01	Oral pharmaceutical preparation for proton pump antagonists
AU2003284786A8 (en)	2004-06-23	Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
MXPA05007253A (es)	2005-12-14	Sales novedosas de derivados anticonvulsivantes.
UA87152C2 (ru)	2009-06-25	Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
MY142077A (en)	2010-08-30	Semi-solid systems containing azetidine derivatives
TW200633717A (en)	2006-10-01	Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
ZA200501010B (en)	2005-08-30	BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
UA87292C2 (ru)	2009-07-10	Применение сирамезина для лечения злокачественных опухолей
ZA200204905B (en)	2003-04-30	Improved pharmaceutical dental formulations.